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A 60-year-old male， who had been maintained on hemodialysis for 4 years， visited our hospital to 
receive living renal transplantation. He complained of macrohematuria， and preoperative exami-
nation showed elevation of psostate specific antigen (PSA). Cystoscopy revealed papillary tumors on 
the right lateral bladder wall. Transurethral resection ofbladder tumor (TUR・Bt)was performed and 
histopathological examination showed transitional cell carcinoma， G2， pTa. The histologic diagnosis 
of the transrectal needle prostate biopsy specimen was moderately differentiated adenocarcinoma. 
Combined androgen blockade as a neoadjuvant therapy and radical prostatectomy were performed. 
A case of synchronous double primary cancers， comprised of adenocarcinoma of the prostate and 
transitional cell carcinoma of the urinary blader in a hemodialysis patient has never been previously 
reported in the ]apanese literature. 
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15.5 ng/ml (基準値 <4.0) と高値を指摘された経
直腸的前立腺針生検施行， Adenocarcinoma of 








入院時検査所見:血液検査では RBC347X 104/mm3 
(400~550 X 104)， Hb 11. 3 g/dl (13. O~ 16. 8)， Ht 
34. 1 % (38. O~ 52. 0)， Cr 10. 4 mg/dl (0. 4~ 1. 2)， 
BUN 37 mg/dl (8. 0~20. 0)， K 5. 4 mEq/l (3. 6~ 
5.0)と，軽度の貧血および一般的な慢性腎不全状態
を認めた他は，特に異常を認めなかった.尿検査では
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Fig. 1. Cystoscopy revealed papillary tumors on 
the right lateral bladder wall. 
Fig. 2. Histopathological examination showed 















CAB療法 (bicalutamide80 mg/day， leuprore1in ace-





目的にて当科再入院となった. Hb 9. 5 g/dl， Ht 
Fig. 3. Gross appearance of the prostate. 
28.6%と貧血の進行を認め，自己血は採取しなかっ





た (Fig.3).病理組織検査は Adenocarcinomaof pro-














Table 1. Cases of bladder cancer in hemodialysis patient reported in J apan 
平均年齢(計83例) 62.0歳 (20-81)
性差(計83例) 男性56例 女性27例
初発までの透析期間 l年未満 ト 5年未満
(平均:58.2カ月) 11/81 03.6%) 41/81 (50.6%) 
主訴 肉眼的(8血尿69/81 (85.2%) 
その他
12/81 (14目8%)
組織型 TCC TCC+その他%) 62/74 (83目8%) 7/74 ( 9.5 
組織学的異型度何CC) GI G2 7/61 (11.5%) 19/61 (31.1%) 
i采達度 8/64p(T1a 25%) l7/64p(T26l .6%) 

























織学的異型度:G1 ; 14.3%， G2; 45.5%， G3; 36.4 
%， Gx; 3. 8% /組織学的深達度:pTO ; O.4%， 
510(年22未2満% 10年以上18/81 (22.2%) 11/81 03.6%) 
その他
5/74 ( 6.8%) 
G3 
35/61 (57.4%) 




40/83 (48.2%) 1/83 ( 1.2%) 
pTis ; 4.5%， pTa; 19. 5%， pTl ; 39. 6%， pT2; 
8.4%， pT3; 8. 3%， pT4; 2. 6%， pTx; 9. 6%) と
比較すると，透析患者の勝脱癌は非透析患者よりも























Table 2. Cases of prostate cancer in hemodialysis patient reported in J apan 
平均年齢(計43例) 70.9歳 (53-86)
初発までの透析期間 1年未満 l-5(年50未0満% 5-lO(年23未.9満% 10年以上(平均:70.6カ月) 4/46 (8.7%) 23/46 (50.0%) 11/46 (23.9%) 8/46 (17.4%) 
初診時 PSA(ng/mJ) 10未(20満.0 10-100未満 loo-10000未%満) /l5，0 O00以上10/50 (20.0%) 30/50 (60.0%) 3/50 ( 6.0%) 
組織学的分化度 高分(26化12/46 (26.1%) 中分(39化18/46 (39. 1 %) 低分(34化16/46 (34.8%) 
病期 B C D 22/51 (43.1%) 14/51 (27.5%) 15/51 (29.4%) 
治療法 4内4分/54泌療(8法1.Sの%み) 内分泌、療法+5放.6射%線)療法3/54 ( 根治的前立(13腺.0全%摘)術7/54 
2005年10号51巻泌尿紀要692 
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